Poria is reported to reduce proteinuria and renal fibrosis in models of DKD and nephrotic syndrome, partly by suppressing ECM buildup and regulating podocyte injury markers like nephrin and podocin (Guo et al., 2024). This evidence concerns the gene NPHS2 and nephrotic syndrome.